Zobrazeno 1 - 10
of 1 423
pro vyhledávání: '"Sata Michio"'
Publikováno v:
Virology Journal, Vol 9, Iss 1, p 282 (2012)
Abstract Background The aims of this study were to evaluate the effects of nutritional supplementation with branched-chain amino acids (BCAA) with zinc component (Aminofeel®) on adherence to and outcome of therapy in patients treated with interferon
Externí odkaz:
https://doaj.org/article/2730a3698ad244a89051a874d12b6f23
Publikováno v:
BMC Gastroenterology, Vol 12, Iss 1, p 155 (2012)
Abstract Background Oral lichen planus (OLP) is seen frequently in patients with hepatitis C virus (HCV) infection. The aim of this study was to evaluate the occurrence of oral candidiasis, other mucosal lesions, and xerostomia during interferon (IFN
Externí odkaz:
https://doaj.org/article/738a930d58344076b46f162b5c132859
Autor:
Toyoda Hidenori, Kumada Takashi, Shimada Noritomo, Takaguchi Koichi, Ide Tatsuya, Sata Michio, Ginba Hiroyuki, Matsuyama Kazuhiro, Izumi Namiki
Publikováno v:
BMC Infectious Diseases, Vol 12, Iss 1, p 324 (2012)
Abstract Background The importance of the reduction in hepatitis C virus (HCV) RNA levels 4 and 12 weeks after starting peginterferon (PEG-IFN) and ribavirin combination therapy has been reported to predict a sustained virologic response (SVR) in pat
Externí odkaz:
https://doaj.org/article/c3f68cda626642499f60fdf045f1f21c
Autor:
Yamasaki Kazumi, Tomohiro Mayumi, Nagao Yumiko, Sata Michio, Shimoda Toshiaki, Hirase Kazuhiro, Shirahama Satoshi
Publikováno v:
BMC Gastroenterology, Vol 12, Iss 1, p 139 (2012)
Abstract Background No study has compared the long-term prognoses of hepatitis C patients with hepatitis C virus (HCV) antibody-negative individuals and investigated the effects of interferon (IFN) treatment. To clarify the long-term prognosis of HCV
Externí odkaz:
https://doaj.org/article/400c1021b7bb4ff782813c3d6b77374c
Autor:
Nagao Yumiko, Sata Michio
Publikováno v:
BMC Research Notes, Vol 5, Iss 1, p 470 (2012)
Abstract Background The aims of this study were to analyze factors motivating the acceptance of interferon (IFN) therapy and to clarify the prevalence of oral mucosal diseases in hepatitis C virus (HCV)-infected Japanese patients treated with IFN. Fi
Externí odkaz:
https://doaj.org/article/21c110dc4d4f42d8b77e52fcfad844a3
Autor:
Nagao Yumiko, Sata Michio
Publikováno v:
BMC Gastroenterology, Vol 12, Iss 1, p 31 (2012)
Abstract Background The aims of this study were to assess the prevalence of hepatitis C virus (HCV) infection in Japanese patients with oral lichen planus and identify the impact of amino acid (aa) substitutions in the HCV core region and IFN-sensiti
Externí odkaz:
https://doaj.org/article/92edd5ac67684d658d5b49beabf3fa5a
Autor:
Sata Michio, Nagao Yumiko
Publikováno v:
Virology Journal, Vol 8, Iss 1, p 348 (2011)
Abstract Background Oral lichen planus (OLP) decreases the quality of life because it can cause spontaneous pain during eating and tooth-brushing and an uncomfortable feeling in the mouth. In addition, OLP may be associated with HCV-related liver dis
Externí odkaz:
https://doaj.org/article/7f225327f95545a4965b3d469476be65
Autor:
Sata Michio, Nagao Yumiko
Publikováno v:
Virology Journal, Vol 7, Iss 1, p 375 (2010)
Abstract Background Hypoalbuminemia has been shown to be associated with increased mortality. We reported a mass screening in 1990 of X town in Japan, which demonstrated a high prevalence of hepatitis C virus (HCV) infection. This follow-up study det
Externí odkaz:
https://doaj.org/article/5026b7529e7149fcaceb572fecff71a0
Autor:
Nagao Yumiko, Sata Michio
Publikováno v:
Virology Journal, Vol 7, Iss 1, p 192 (2010)
Abstract Background There has been little discussion about the importance of oral management and interferon (IFN) therapy, although management of the side effects of therapy for chronic hepatitis C has been documented. This study determined whether d
Externí odkaz:
https://doaj.org/article/8c51fa57de9944b4a4de2177da68efaf
Autor:
Sakamoto Masaharu, Selvendiran Karuppaiyah, Nakamura Toru, Torimura Takuji, Shinkawa Masako, Hashimoto Osamu, Koga Hironori, Ueno Takato, Sata Michio
Publikováno v:
BMC Cancer, Vol 6, Iss 1, p 292 (2006)
Abstract Background Wee1 kinase plays a critical role in maintaining G2 arrest through its inhibitory phosphorylation of cdc2. In previous reports, a pyridopyrimidine molecule PD0166285 was identified to inhibit Wee1 activity at nanomolar concentrati
Externí odkaz:
https://doaj.org/article/ddbb36d2c3e44458a7607363f90c0dc1